nach oben

Journal of Neurology

Erschienen in:

10.06.2020 | COVID-19 | Review Zur Zeit gratis

Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis

verfasst von: Lei Wang, Yin Shen, Man Li, Haoyu Chuang, Youfan Ye, Hongyang Zhao, Haijun Wang

Erschienen in: Journal of Neurology | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Coronavirus disease 2019 (COVID-19) has become a global pandemic, affecting millions of people. However, clinical research on its neurological manifestations is thus far limited. In this study, we aimed to systematically collect and investigate the clinical manifestations and evidence of neurological involvement in COVID-19.

Methods

Three medical (Medline, Embase, and Scopus) and two preprints (BioRxiv and MedRxiv) databases were systematically searched for all published articles on neurological involvement in COVID-19 since the outbreak. All included studies were systematically reviewed, and selected clinical data were collected for meta-analysis via random-effects.

Results

A total of 41 articles were eligible and included in this review, showing a wide spectrum of neurological manifestations in COVID-19. The meta-analysis for unspecific neurological symptoms revealed that the most common manifestations were fatigue (33.2% [23.1–43.3]), anorexia (30.0% [23.2–36.9]), dyspnea/shortness of breath (26.9% [19.2–34.6]), and malaise (26.7% [13.3–40.1]). The common specific neurological symptoms included olfactory (35.7–85.6%) and gustatory (33.3–88.8%) disorders, especially in mild cases. Guillain–Barré syndrome and acute inflammation of the brain, spinal cord, and meninges were repeatedly reported after COVID-19. Laboratory, electrophysiological, radiological, and pathological evidence supported neurologic involvement of COVID-19.

Conclusions

Neurological manifestations are various and prevalent in COVID-19. Emerging clinical evidence suggests neurological involvement is an important aspect of the disease. The underlying mechanisms can include both direct invasion and maladaptive inflammatory responses. More studies should be conducted to explore the role of neurological manifestations in COVID-19 progression and to verify their underlying mechanisms.

Nur mit Berechtigung zugänglich

Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, Dong L, Ma X, Zhang HJ, Gao BL (2020) Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect 80(4):394–400. https://doi.org/10.1016/j.jinf.2020.02.017CrossRefPubMedPubMedCentral

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China Jama. https://doi.org/10.1001/jama.2020.1585CrossRefPubMed

Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J (2020) The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. https://doi.org/10.1093/jtm/taaa021CrossRefPubMedPubMedCentral

Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, Chen G, Zhang Y, Li D, Li J, Lian H, Niu S, Zhang L, Zhang J (2020) Characteristics of COVID-19 infection in Beijing. J Infect 80(4):401–406. https://doi.org/10.1016/j.jinf.2020.02.018CrossRefPubMedPubMedCentral

Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, Singh B, Sen MK, Covid Working Group SH (2020) Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis. https://doi.org/10.4081/monaldi.2020.1294CrossRefPubMed

Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, Dai J, Sun Q, Zhao F, Qu J, Yan F (2020) Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect 80(4):388–393. https://doi.org/10.1016/j.jinf.2020.02.016CrossRefPubMedPubMedCentral

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091. https://doi.org/10.1136/bmj.m1091CrossRefPubMedPubMedCentral

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMed

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 133(9):1025–1031. https://doi.org/10.1097/cm9.0000000000000744CrossRef

10.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5):475–481. https://doi.org/10.1016/s2213-2600(20)30079-5CrossRefPubMedPubMedCentral

11.

Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, Pan H (2020) Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 127:104364. https://doi.org/10.1016/j.jcv.2020.104364CrossRefPubMedPubMedCentral

12.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736%2820%2930183-5CrossRefPubMedPubMedCentral

13.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ (2020) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368:m606. https://doi.org/10.1136/bmj.m606CrossRefPubMedPubMedCentral

14.

Covid-19 National Emergency Response Center E, Case Management Team KCfDC, Prevention (2020) Early epidemiological and clinical characteristics of 28 cases of coronavirus disease in South Korea. Osong Public Health Res Perspect 11(1):8–14. https://doi.org/10.24171/j.phrp.2020.11.1.03CrossRef

15.

Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY, Shen YF, Shi CW, Lian X, Chu JG, Chen L, Wang ZY, Ren DW, Li GX, Chen XQ, Shen HJ, Chen XM (2020) Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series. Qjm Epub. https://doi.org/10.1093/qjmed/hcaa089CrossRef

16.

Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, Sharma L (2020) Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA 323(11):1092–1093. https://doi.org/10.1001/jama.2020.1623CrossRefPubMedPubMedCentral

17.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736%2820%2930211-7CrossRefPubMedPubMedCentral

18.

Zhang X, Cai H, Hu J, Lian J, Gu J, Zhang S, Ye C, Lu Y, Jin C, Yu G, Jia H, Zhang Y, Sheng J, Li L, Yang Y (2020) Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. Int J Infect Dis 94:81–87. https://doi.org/10.1016/j.ijid.2020.03.040CrossRefPubMedPubMedCentral

19.

Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, Chen B, Zhang Z, Guan W, Ling Z, Jiang R, Hu T, Ding Y, Lin L, Gan Q, Luo L, Tang X, Liu J (2020) Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 47(5):1275–1280. https://doi.org/10.1007/s00259-020-04735-9CrossRefPubMed

20.

Fan H, Zhang L, Huang B, Zhu M, Zhou Y, Yu W, Zhu L, Cheng S, Tao X, Zhang H, Chen J (2020) Retrospective analysis of clinical features in 101 death cases with COVID-19. medRxiv. https://doi.org/10.1101/2020.03.09.20033068CrossRefPubMedPubMedCentral

21.

Leung KS-S, Ng TT-L, Wu AK-L, Yau MC-Y, Lao H-Y, Choi M-P, Tam KK-G, Lee L-K, Wong BK-C, Ho AY-M, Yip K-T, Lung K-C, Liu RW-T, Tso EY-K, Leung W-S, Chan M-C, Ng Y-Y, Sin K-M, Fung KS-C, Chau SK-Y, To W-K, Que T-L, Shum DH-K, Yip SP, Yam W-C, Siu GKH (2020) A territory-wide study of early COVID-19 outbreak in Hong Kong community: a clinical, epidemiological and phylogenomic investigation. medRxiv. https://doi.org/10.1101/2020.03.30.20045740CrossRefPubMedPubMedCentral

22.

Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S (2020) Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv. https://doi.org/10.1101/2020.03.16.20035105CrossRefPubMedPubMedCentral

23.

Levinson R, Elbaz M, Ben-Ami R, Shasha D, Levinson T, Choshen G, Petrov K, Gadoth A, Paran Y (2020) Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection. medRxiv. https://doi.org/10.1101/2020.04.11.20055483CrossRefPubMedPubMedCentral

24.

Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS (2020) Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.22579CrossRefPubMedPubMedCentral

25.

Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. https://doi.org/10.1002/jmv.25915CrossRefPubMedPubMedCentral

26.

Zhang T, Rodricks MB, Hirsh E (2020) COVID-19-Associated acute disseminated encephalomyelitis: a case report. medRxiv. https://doi.org/10.1101/2020.04.16.20068148CrossRefPubMedPubMedCentral

27.

Poyiadji NA-O, Shahin GA-O, Noujaim DA-O, Stone MA-O, Patel SA-O, Griffith BA-O (2020) COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. https://doi.org/10.1148/radiol.2020201187CrossRefPubMed

28.

Ye M, Ren Y, Lv T (2020) Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun Epub. https://doi.org/10.1016/j.bbi.2020.04.017CrossRef

29.

Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V, Zayet S (2020) Features of anosmia in COVID-19. Medecine et Maladies Infectieuses. https://doi.org/10.1016/j.medmal.2020.04.006CrossRefPubMedPubMedCentral

30.

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58. https://doi.org/10.1016/j.ijid.2020.03.062CrossRefPubMedPubMedCentral

31.

Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. https://doi.org/10.1016/j.jocn.2020.04.062CrossRefPubMedPubMedCentral

32.

Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med Epub. https://doi.org/10.1056/NEJMc2009191CrossRef

33.

Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T, Balaan M, Bhanot N (2020) Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. https://doi.org/10.1016/j.idcr.2020.e00771CrossRefPubMedPubMedCentral

34.

Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19:383–384. https://doi.org/10.1016/s1474-4422(20)30109-5CrossRefPubMedPubMedCentral

35.

Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, de Aragón-Gómez F, Benito-León J (2020) Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. https://doi.org/10.1212/wnl.0000000000009619CrossRefPubMed

36.

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med Epub. https://doi.org/10.1056/NEJMc2008597CrossRef

37.

Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-05965-1CrossRefPubMedPubMedCentral

38.

Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, Mouchtouris N, Philipp L, Peiper SC, Wang ZX, Rincon F, Tjoumakaris SI, Jabbour P, Rosenwasser RH, Gooch MR (2020) Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2020-323522CrossRefPubMed

39.

Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, Nocivelli S, Pezzini A, Foca E, Caruso A, Leonardi M, Pasolini MP, Gasparotti R, Castelli F, Padovani A (2020) Steroid-responsive severe encephalopathy in SARS-CoV-2 infection. medRxiv. https://doi.org/10.1101/2020.04.12.20062646CrossRef

40.

Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C (2020) Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. https://doi.org/10.1001/jamaoto.2020.0832CrossRefPubMed

41.

Bernard-Valnet R, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M, Cerruti-Sola J, Rossetti AO, Du Pasquier R (2020) Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection. medRxiv. https://doi.org/10.1101/2020.04.17.20060251CrossRef

42.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.1127CrossRefPubMedPubMedCentral

43.

Li YC, Bai WZ, Hashikawa T (2020) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. https://doi.org/10.1002/jmv.25728CrossRefPubMedPubMedCentral

44.

Deng Y, Tan X, Li ML, Wang WZ, Wang YK (2019) Angiotensin-converting enzyme 2 in the rostral ventrolateral medulla regulates cholinergic signaling and cardiovascular and sympathetic responses in hypertensive rats. Neurosci Bull 35(1):67–78. https://doi.org/10.1007/s12264-018-0298-3CrossRefPubMed

45.

Chen R, Wang K, Yu J, Chen Z, Wen C, Xu Z (2020) The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. bioRxiv. https://doi.org/10.1101/2020.04.07.030650CrossRefPubMedPubMedCentral

46.

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82(15):7264–7275. https://doi.org/10.1128/jvi.00737-08CrossRefPubMedPubMedCentral

47.

Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, Chance R, Macaulay IC, Chou H-j, Fletcher R, Das D, Street K, de Bezieux HR, Choi Y-G, Risso D, Dudoit S, Purdom E, Mill JS, Hachem RA, Matsunami H, Logan DW, Goldstein BJ, Grubb MS, Ngai J, Datta SR (2020) Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. bioRxiv. https://doi.org/10.1101/2020.03.25.009084CrossRef

48.

Fodoulian L, Tuberosa J, Rossier D, Landis BN, Carleton A, Rodriguez I (2020) SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. bioRxiv. https://doi.org/10.1101/2020.03.31.013268CrossRef

49.

Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, Talbot PJ (2019) Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. https://doi.org/10.3390/v12010014CrossRefPubMedPubMedCentral

50.

Meneses G, Cárdenas G, Espinosa A, Rassy D, Pérez-Osorio IN, Bárcena B, Fleury A, Besedovsky H, Fragoso G, Sciutto E (2019) Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury. Ann N Y Acad Sci 1437(1):43–56. https://doi.org/10.1111/nyas.13985CrossRefPubMed

51.

Eccles R (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5(11):718–725. https://doi.org/10.1016/s1473-3099(05)70270-xCrossRefPubMedPubMedCentral

52.

Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, Tang H, Nishiura K, Peng J, Tan Z, Wu T, Cheung KW, Chan KH, Alvarez X, Qin C, Lackner A, Perlman S, Yuen KY, Chen Z (2019) Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. https://doi.org/10.1172/jci.insight.123158CrossRefPubMedPubMedCentral

53.

Bolles M, Deming D, Long K, Agnihothram S, Whitmore A, Ferris M, Funkhouser W, Gralinski L, Totura A, Heise M, Baric RS (2011) A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol 85(23):12201–12215. https://doi.org/10.1128/jvi.06048-11CrossRefPubMedPubMedCentral

Titel: Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis
verfasst von: Lei Wang
Yin Shen
Man Li
Haoyu Chuang
Youfan Ye
Hongyang Zhao
Haijun Wang
Publikationsdatum: 10.06.2020
Verlag: Springer Berlin Heidelberg
Schlagwörter: COVID-19
Neurologische Beteiligung bei Infektionserkrankungen
Polyneuritis und Polyneuroradikulitis Typ Guillain-Barré
Myalgie
Apoplex
Erschienen in: Journal of Neurology / Ausgabe 10/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09974-2

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Vorhofflimmern

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Vorhofflimmern

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2020

A novel conversion prediction method of MCI to AD based on longitudinal dynamic morphological features using ADNI structural MRIs

Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse

Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis

Cerebral venous thrombosis: clinical predictors and emerging treatments

Season of birth and multiple sclerosis: a systematic review and multivariate meta-analysis

Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis

Passend zum Thema

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Abbott Structural Heart